Pergolide potentiates L-DOPA-induced dopamine release in rat striatum after lesioning with 6-hydroxydopamine

Journal of Neural Transmission

Volumn 106, Issue 2, 1999, Pages 145-158

  Dethy, S ^a   Laute, M A ^a   Damhaut, P ^a   Goldman, S ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

6 Hydroxydopamine; Brain microdialysis; Dopamine; Parkinson's disease; Pergolide; Striatum

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE; HOMOVANILLIC ACID; LEVODOPA; OXIDOPAMINE; PERGOLIDE;

ANIMAL EXPERIMENT; ARTICLE; CORPUS STRIATUM; DENERVATION; DOPAMINE RELEASE; DRUG TRANSFORMATION; INTRAPERITONEAL DRUG ADMINISTRATION; LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

3,4-DIHYDROXYPHENYLACETIC ACID; AMPHETAMINE; ANIMALS; DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINE AGONISTS; DRUG SYNERGISM; HOMOVANILLIC ACID; HYDROXYINDOLEACETIC ACID; LEVODOPA; MALE; MICRODIALYSIS; MOTOR ACTIVITY; NEOSTRIATUM; NEURONS; OXIDOPAMINE; PARKINSON DISEASE, SECONDARY; PERGOLIDE; RATS; RATS, WISTAR;

EID: 0033052489     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020050147     Document Type: Article

References (32)

1. Abercrombie ED, Bunatz AE, Zigmond MJ (1990) Effects of L-DOPA on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats. Brain Res 525: 36-44
2. Arnt J, Hyttel J (1985) Differential involvement of dopamine D-1 and D-2 receptors in the circling behaviour induced by apomorphine, SK & F 38393, pergolide and LY 171555 in 6-hydroxydopamine-lesioned rats. Psychopharmacol 85: 346-352
3. Berger K, Przedborski S, Cadet JL (1990) Retrograde degeneration of nigrostriatal neurons induced by intrastriatal 6-hydroxydopamine injection in rats. Brain Res Bull 26: 301-307
4. Brannan T, Knott P, Kaufmann H, Yahr M (1990) In vivo studies of striatal dopamine release and metabolism following adiministration of L-Dopa. Adv Neurol 53: 75-81
5. Carlsson A (1975) Receptor-mediated control of dopamine metabolism. In: Usdin E, Bunney WE (eds) Pre-and postsynaptic receptors. Dekker, New York, pp 49-63
6. Castaneda E, Whishaw IQ, Robinson TE (1990) Changes in striatal dopamine neurotransmission assessed with microdialysis following recovery from a bilateral 6-OHDA lesion: variation as a function of lesion size. J Neurosci 10(6): 1847-1854
7. Dethy S, Laute MA, Luxen A, Hildebrand J, Goldman S (1995) Effect of pergolide on endogenous and exogenous L-DOPA metabolism in the rat striatum: a microdialysis study. J Neural Transm 101: 1-11
8. Factor SA, Ramos JRS, Weiner WJ (1988) Parkinson's disease: an open label trial of pergolide in patients failing bromocriptine therapy. J Neurol Neurosurg Psychiatry 51: 529-533
9. Fuller RW, Clemens JA, Hynes MD (1982) Degree of selectivity of pergolide as an agonist at presynaptic versus postsynaptic dopamine receptors: implications for prevention or treatment of tardive dyskinesia. J Clin Psychopharmacol 2: 371-375
10. Imperato A, Chiara GD (1988) Effects of locally applied D-1 and D-2 receptor agonists and antagonists studied with brain dialysis. Eur J Pharmacol 156: 385-393
11. Imperato A, Tanda G. Frau R, Chiara GD (1988) Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats. J Pharmacol Exp Ther 245: 257-264
12. Koshimura K, Ohue T, Akiyama Y, Itoh A, Miwa S (1992) L-DOPA administration enhances exocytotic dopamine release in vivo in the rat striatum. Life Sci 51: 747-755
13. Kurata K. Shibata R (1990) Biphasic effect of locally applied apomorphine and 2,3,4,5-tetrahydro-7,8-dihydroxy-l-phenyl-lII-3-benzazepine on the release of striatal dopamine investigated by means of brain dialysis. Neurosci Lett 117: 264-268
14. Meiergerd SM, Patterson TA, Schenk JO (1993) D2 receptors may modulate the function vivo. J Neurochem 61: 764-767
15. 3H]L-dopa in rats. Biochem Pharmacol 39: 1853-1860
16. Montastruc JL, Rascol O, Senard JM, Rascol A (1994) A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five-year follow-up. J Neurol Neurosurg Psychiatry 57: 1034-1038
17. Nowycky MC, Roth RH (1978) Dopaminergic neurons: role of presynaptic receptors in the regulation of transmitter biosynthesis. Prog Neuropsychopharmacol 2: 139-158
18. Olanow CW (1988) Single-blind double observer-controlled study of carbidopa/levodopa vs bromocriptine in untreated Parkinsonian patients: a 3 year follow-up. Arch Neurol 45: 206
19. Osborne PG, O'Connor WT. Beck O, Ungerstedt U (1994) Acute versus chronic haloperidol: relationship between tolerance to catalepsy and striatal and accumbens dopamine, GABA and acetylcholine release. Brain Res 634: 20-30
20. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic Press, San Diego
21. Przedborski S. Levivier M. Jiang H, Ferreira M, Jackson-Lewis V, Donaldson D, Togasaki DM (1995) Dose-dependent lesions of the dopaminergic nigrostrial pathway induced by intrastriatal injection of 6-hydroxydopamine. Neuroscience 676: 31-647
22. Reith MEA, Xu C, Chen NH (1997) Pharmacology and regulation of the neuronal dopamine transporter. Eur J Pharmacol 324: 1-10
23. Robinson TE, Mocsary Z, Camp DM, Whishaw IQ (1994) Time course of recovery of extracellular dopamine following partial damage to the nigrostriatal dopamine system. J Neurosci 14(5): 2687-2696
24. Santiago M, Westerink BHC (1991) The regulation of dopamine release from nigrostriatal neurons in conscious rats: the role of somatodendric autoreceptors. J Pharmacol 204: 79-85
25. Sarre S, Herregodts P, Deleu D, Devrieze A, Kippel ND, Ebinger G, Michotte Y (1992) Biotransformation of L-DOPA in striatum and substancia nigra of rats with a unilateral, nigrostriatal lesion: a microdialysis study. Naunyn Schmiedebergs Arch Pharmacol 346: 277-285
26. Sarre S, Klippel ND, Herregodts P, Ebinger G, Michotte Y (1994) Biotransformation of locally applied L-dopa in the corpus striatum of the hemi-Parkinsonian rat studied with microdialysis. Naunyn Schmiedebergs Arch Pharmacol 350: 15-21
27. Sarre S, Ebinger G, Michotte Y (1995) Levodopa biotransformation in hemi-parkinson rats: effect of dopamine receptor agonists and antagonists. Eur J Pharmacol 296: 247-260
28. See RS, Sorg BA, Chapman MA, Kalivas PW (1991) In vivo assessment of release and metabolism of dopamine in the ventrolateral striatum of awake rats following administration of dopamine D1 and D2 receptor agonists and antagonists. Neuropharmacol 30: 1269-1274
29. Westerink BHC (1991) Microdialysis compared with other in vivo release models. In: Robinson TE, Justice JB (eds) Microdialysis in the neurosciences. Elsevier Science Publishers B.V., Amsterdam, pp 23-43
30. Zetterström T, Ungerstedt U (1984) Effects of apomorphine on the in vivo release of dopamine and its metabolites, studied by brain dialysis. Eur J Pharmacol 97: 29-36
31. Zetterström T. Herrera-Marschitz M, Ungerstedt U (1986) Simultaneous measurement of dopamine release and rotational behaviour in 6-hydroxydopamine denervated rats using intracerebral dialysis. Brain Res 376: 1-7
32. Zhu M, Juorio AV, Paterson IA, Boulton AA (1993) Regulation of striatal aromatic L-amino acid decarboxylase: effects of blockade or activation of dopamine receptors. Eur J Pharmacol 238: 157-164